Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients
Clinical trial NCT00548769 · COMPLETED
Trial details
- NCT number
- NCT00548769
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-21
- Primary completion
- 2007-11-26
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.